drug development

The investment is aimed at augmenting R&D and IP in drug development

The drug, which may improve life expectancy and quality for pancreatic cancer patients, was discovered after examining a hormone…

According to the INST team, till-date there is no study reported where a combination of two anti-leishmanial drugs has been…

AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical…

The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies 

Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to…

Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, is currently in a first-in-human Phase 1/2 clinical study…

Genetics is questioning the wisdom behind the old gold standard of randomised populations used for trials. While large randomised…

The new technique involving the use of inert oils to control evaporative solvent loss can unlock the potential of accelerated new…

Dr Nir London, Senior Scientist, Department of Organic Chemistry, The Weizmann Institute of Science, has brought together a wide…